-
1
-
-
20044386299
-
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties
-
Larsen CP, et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant. 2005;5(3):443–453.
-
(2005)
Am J Transplant
, vol.5
, Issue.3
, pp. 443-453
-
-
Larsen, CP1
-
2
-
-
76949101581
-
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)
-
Vincenti F, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant. 2010;10(3):535–546.
-
(2010)
Am J Transplant
, vol.10
, Issue.3
, pp. 535-546
-
-
Vincenti, F1
-
3
-
-
84955444904
-
Belatacept and long-term outcomes in kidney transplantation
-
Vincenti F, et al. Belatacept and long-term outcomes in kidney transplantation. N Engl J Med. 2016;374(4):333–343.
-
(2016)
N Engl J Med
, vol.374
, Issue.4
, pp. 333-343
-
-
Vincenti, F1
-
4
-
-
77956528156
-
Five-year safety and efficacy of belatacept in renal transplantation
-
Vincenti F, et al. Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol. 2010;21(9):1587–1596.
-
(2010)
J Am Soc Nephrol
, vol.21
, Issue.9
, pp. 1587-1596
-
-
Vincenti, F1
-
5
-
-
0036664218
-
Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice
-
Valujskikh A, Pantenburg B, Heeger PS. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant. 2002;2(6):501–509.
-
(2002)
Am J Transplant
, vol.2
, Issue.6
, pp. 501-509
-
-
Valujskikh, A1
Pantenburg, B2
Heeger, PS.3
-
6
-
-
0037108492
-
Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients
-
Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol. 2002;169(8):4667–4673.
-
(2002)
J Immunol
, vol.169
, Issue.8
, pp. 4667-4673
-
-
Zhai, Y1
Meng, L2
Gao, F3
Busuttil, RW4
Kupiec-Weglinski, JW.5
-
7
-
-
33747500656
-
The impact of memory T cells on rejection and the induction of tolerance
-
Brook MO, Wood KJ, Jones ND. The impact of memory T cells on rejection and the induction of tolerance. Transplantation. 2006;82(1):1–9.
-
(2006)
Transplantation
, vol.82
, Issue.1
, pp. 1-9
-
-
Brook, MO1
Wood, KJ2
Jones, ND.3
-
8
-
-
84855943600
-
Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells
-
Kitchens WH, et al. Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells. Am J Transplant. 2012;12(1):69–80.
-
(2012)
Am J Transplant
, vol.12
, Issue.1
, pp. 69-80
-
-
Kitchens, WH1
-
9
-
-
84874644839
-
Costimulation blockade: current perspectives and implications for therapy
-
Kinnear G, Jones ND, Wood KJ. Costimulation blockade: current perspectives and implications for therapy. Transplantation. 2013;95(4):527–535.
-
(2013)
Transplantation
, vol.95
, Issue.4
, pp. 527-535
-
-
Kinnear, G1
Jones, ND2
Wood, KJ.3
-
10
-
-
59849096875
-
OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade
-
Burrell BE, Lu G, Li XC, Bishop DK. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol. 2009;182(1):379–390.
-
(2009)
J Immunol
, vol.182
, Issue.1
, pp. 379-390
-
-
Burrell, BE1
Lu, G2
Li, XC3
Bishop, DK.4
-
11
-
-
33847152240
-
Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation
-
Ford ML, et al. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J Exp Med. 2007;204(2):299–309.
-
(2007)
J Exp Med
, vol.204
, Issue.2
, pp. 299-309
-
-
Ford, ML1
-
12
-
-
84929000784
-
TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients
-
Chauvin JM, et al. TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients. J Clin Invest. 2015;125(5):2046–2058.
-
(2015)
J Clin Invest
, vol.125
, Issue.5
, pp. 2046-2058
-
-
Chauvin, JM1
-
13
-
-
84946771300
-
TIGIT predominantly regulates the immune response via regulatory T cells
-
Kurtulus S, et al. TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Invest. 2015;125(11):4053–4062.
-
(2015)
J Clin Invest
, vol.125
, Issue.11
, pp. 4053-4062
-
-
Kurtulus, S1
-
14
-
-
0034642499
-
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
-
Bachmaier K, et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature. 2000;403(6766):211–216.
-
(2000)
Nature
, vol.403
, Issue.6766
, pp. 211-216
-
-
Bachmaier, K1
-
15
-
-
0028316562
-
Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells
-
Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol. 1994;152(6):2675–2685.
-
(1994)
J Immunol
, vol.152
, Issue.6
, pp. 2675-2685
-
-
Croft, M1
Bradley, LM2
Swain, SL.3
-
16
-
-
85021389136
-
Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens
-
Ashokkumar C, et al. Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens. Sci Rep. 2015;5:15218.
-
(2015)
Sci Rep
, vol.5
, pp. 15218
-
-
Ashokkumar, C1
-
17
-
-
77956818277
-
The role of OX40 (CD134) in T-cell memory generation
-
Weinberg AD. The role of OX40 (CD134) in T-cell memory generation. Adv Exp Med Biol. 2010;684:57–68.
-
(2010)
Adv Exp Med Biol
, vol.684
, pp. 57-68
-
-
Weinberg, AD.1
-
18
-
-
31144460031
-
Critical, but conditional, role of OX40 in memory T cell-mediated rejection
-
Vu MD, Clarkson MR, Yagita H, Turka LA, Sayegh MH, Li XC. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol. 2006;176(3):1394–1401.
-
(2006)
J Immunol
, vol.176
, Issue.3
, pp. 1394-1401
-
-
Vu, MD1
Clarkson, MR2
Yagita, H3
Turka, LA4
Sayegh, MH5
Li, XC.6
-
19
-
-
33846399187
-
+ memory T cell survival and significantly increases recall responses
-
+ memory T cell survival and significantly increases recall responses. Eur J Immunol. 2007;37(1):157–166.
-
(2007)
Eur J Immunol
, vol.37
, Issue.1
, pp. 157-166
-
-
Ruby, CE1
Redmond, WL2
Haley, D3
Weinberg, AD.4
-
20
-
-
58749086427
-
OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells
-
Mousavi SF, et al. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells. J Immunol. 2008;181(9):5990–6001.
-
(2008)
J Immunol
, vol.181
, Issue.9
, pp. 5990-6001
-
-
Mousavi, SF1
-
21
-
-
84911103917
-
Autophagy is essential for effector CD8(+) T cell survival and memory formation
-
Xu X, et al. Autophagy is essential for effector CD8(+) T cell survival and memory formation. Nat Immunol. 2014;15(12):1152–1161.
-
(2014)
Nat Immunol
, vol.15
, Issue.12
, pp. 1152-1161
-
-
Xu, X1
-
22
-
-
34948883517
-
+ Tregs
-
+ Tregs. Blood. 2007;110(7):2501–2510.
-
(2007)
Blood
, vol.110
, Issue.7
, pp. 2501-2510
-
-
Vu, MD1
-
24
-
-
0037443415
-
The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo
-
Yuan X, et al. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo. J Immunol. 2003;170(6):2949–2955.
-
(2003)
J Immunol
, vol.170
, Issue.6
, pp. 2949-2955
-
-
Yuan, X1
-
25
-
-
84897061290
-
Memory T cells mediate cardiac allograft vasculopathy and are inactivated by anti-OX40L monoclonal antibody
-
Wang H, et al. Memory T cells mediate cardiac allograft vasculopathy and are inactivated by anti-OX40L monoclonal antibody. Cardiovasc Drugs Ther. 2014;28(2):115–122.
-
(2014)
Cardiovasc Drugs Ther
, vol.28
, Issue.2
, pp. 115-122
-
-
Wang, H1
-
26
-
-
0142122407
-
Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection
-
Ehst BD, Ingulli E, Jenkins MK. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant. 2003;3(11):1355–1362.
-
(2003)
Am J Transplant
, vol.3
, Issue.11
, pp. 1355-1362
-
-
Ehst, BD1
Ingulli, E2
Jenkins, MK.3
-
27
-
-
0036604427
-
Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen
-
Dudani R, et al. Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen. J Immunol. 2002;168(11):5737–5745.
-
(2002)
J Immunol
, vol.168
, Issue.11
, pp. 5737-5745
-
-
Dudani, R1
-
28
-
-
0142185336
-
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
-
Betts MR, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281(1–2):65–78.
-
(2003)
J Immunol Methods
, vol.281
, Issue.1–2
, pp. 65-78
-
-
Betts, MR1
|